Yang G - Search Results

1

Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP).

Ji L, Song W, Fang H, Li W, Geng J, Wang Y, Guo L, Cai H, Yang T, Li H, Yang G, Li Q, Liu K, Li S, Liu Y, Shi F, Li X, Gao X, Tian H, Ji Q, Su Q, Zhou Z, Wang W, Zhou Z, Li X, Xu Y, Ning Z, Cao H, Pan D, Yao H, Lu X, Jia W. Ji L, et al. Among authors: yang t, yang g. Sci Bull (Beijing). 2021 Aug 15;66(15):1571-1580. doi: 10.1016/j.scib.2021.03.019. Epub 2021 Mar 23. Sci Bull (Beijing). 2021. PMID: 36654286 Free article. Clinical Trial.

2

A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.

Zhang XZ, Wang B, Yang J, Xuan M, Song LG, Li H, Guo XH, Lü XF, Xue QY, Yang GY, Ji QH, Shen J, Liu ZM, Li CJ, Wu TF, Tong XC, Jia Y. Zhang XZ, et al. Chin Med J (Engl). 2009 Dec 20;122(24):2933-8. Chin Med J (Engl). 2009. PMID: 20137477 Clinical Trial.

3

[The efficacy and safety of recombinant human insulin injection in the treatment of diabetic patients:a multicenter, randomized, controlled and open-labeled clinical trial].

Che TT, Wang X, Liu YY, Tian HM, Yang GY, Xu M, Xiao CQ, Zhu LY, Lü XF, Yu HL, Zhang XX, Ren Y. Che TT, et al. Zhonghua Nei Ke Za Zhi. 2011 Jan;50(1):23-6. Zhonghua Nei Ke Za Zhi. 2011. PMID: 21418883 Clinical Trial. Chinese.

4

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.

Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G, Yang L, Lin J, Liu Z, Hagopian WA, Leslie RD; LADA China Study Group. Zhou Z, et al. Among authors: yang l. Diabetes. 2013 Feb;62(2):543-50. doi: 10.2337/db12-0207. Epub 2012 Oct 18. Diabetes. 2013. PMID: 23086039 Free PMC article.

5

Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.

Li Y, Xuan M, Wang B, Yang J, Zhang H, Zhang XZ, Guo XH, Lü XF, Xue QY, Yang GY, Ji QH, Liu ZM, Li CJ, Wu TF, Sheng ZY, Li PQ, Tong JC. Li Y, et al. Chin Med J (Engl). 2013 Feb;126(3):457-63. Chin Med J (Engl). 2013. PMID: 23422107 Clinical Trial.

6

Efficacy and safety of traditional chinese medicine for diabetes: a double-blind, randomised, controlled trial.

Ji L, Tong X, Wang H, Tian H, Zhou H, Zhang L, Li Q, Wang Y, Li H, Liu M, Yang H, Gao Y, Li Y, Li Q, Guo X, Yang G, Zhang Z, Zhou Z, Ning G, Chen Y, Paul S; Evidence-Based Medical Research of Xiaoke Pill Study Group. Ji L, et al. Among authors: yang g, yang h. PLoS One. 2013;8(2):e56703. doi: 10.1371/journal.pone.0056703. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460810 Free PMC article. Clinical Trial.

7

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.

Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D; CCMR Advisory Board; CCMR-3B STUDY Investigators. Ji L, et al. Am J Med. 2013 Oct;126(10):925.e11-22. doi: 10.1016/j.amjmed.2013.02.035. Epub 2013 Jun 27. Am J Med. 2013. PMID: 23810406

8

Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study.

Gu W, Liang L, Wang S, Wang Y, Wu Y, Tian J, Yang G, Piao C, Li Y, Yin J, Xin X, Tan X, Ning G, Wang W; SUNSHINE Study Group. Gu W, et al. Among authors: yang g. J Diabetes. 2016 Nov;8(6):809-815. doi: 10.1111/1753-0407.12360. Epub 2016 Mar 6. J Diabetes. 2016. PMID: 26676908

9

Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study.

Zhou X, Ji L, Ran X, Su B, Ji Q, Pan C, Weng J, Ma C, Hao C, Zhang D, Hu D; CCMR Advisory Board; CCMR-3B Study Investigators. Zhou X, et al. PLoS One. 2016 Jan 4;11(1):e0144179. doi: 10.1371/journal.pone.0144179. eCollection 2016. PLoS One. 2016. PMID: 26726883 Free PMC article.

10

Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial.

Yang W, Zhu L, Meng B, Liu Y, Wang W, Ye S, Sun L, Miao H, Guo L, Wang Z, Lv X, Li Q, Ji Q, Zhao W, Yang G. Yang W, et al. Among authors: yang g. J Diabetes Investig. 2016 Jan;7(1):85-93. doi: 10.1111/jdi.12364. Epub 2015 May 25. J Diabetes Investig. 2016. PMID: 26816605 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,974 results

Search Page